Identifying heterogeneity among injection drug users: a cluster analysis approach
- PMID: 18556614
- PMCID: PMC2446470
- DOI: 10.2105/AJPH.2007.120741
Identifying heterogeneity among injection drug users: a cluster analysis approach
Abstract
Objectives: We used cluster analysis to subdivide a population of injection drug users and identify previously unknown behavioral heterogeneity within that population.
Methods: We applied cluster analysis techniques to data collected in a cross-sectional survey of injection drug users in Winnipeg, Manitoba. The clustering variables we used were based on receptive syringe sharing, ethnicity, and types of drugs injected.
Results: Seven clusters were identified for both male and female injection drug users. Some relationships previously revealed in our study setting, such as the known relationship between Talwin (pentazocine) and Ritalin (methylphenidate) use, injection in hotels, and hepatitis C virus prevalence, were confirmed through our cluster analysis approach. Also, relationships between drug use and infection risk not previously observed in our study setting were identified, an example being a cluster of female crystal methamphetamine users who exhibited high-risk behaviors but an absence or low prevalence of blood-borne pathogens.
Conclusions: Cluster analysis was useful in both confirming relationships previously identified and identifying new ones relevant to public health research and interventions.
Similar articles
-
Demographic, risk behaviour and personal network variables associated with prevalent hepatitis C, hepatitis B, and HIV infection in injection drug users in Winnipeg, Canada.BMC Public Health. 2006 Sep 13;6:229. doi: 10.1186/1471-2458-6-229. BMC Public Health. 2006. PMID: 16970811 Free PMC article.
-
Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.J Urban Health. 2007 May;84(3):436-54. doi: 10.1007/s11524-007-9178-2. J Urban Health. 2007. PMID: 17356901 Free PMC article.
-
Circumstances surrounding the first injection experience and their association with future syringe sharing behaviors in young urban injection drug users.Drug Alcohol Depend. 2005 Mar 7;77(3):303-9. doi: 10.1016/j.drugalcdep.2004.08.021. Drug Alcohol Depend. 2005. PMID: 15734230
-
Determinants of injection drug user (IDU) syringe sharing: the relationship between availability of syringes and risk network member characteristics in Winnipeg, Canada.Addiction. 2007 Oct;102(10):1626-35. doi: 10.1111/j.1360-0443.2007.01940.x. Addiction. 2007. PMID: 17854339
-
Correlates of hepatitis C virus infections among injection drug users.Medicine (Baltimore). 1995 Jul;74(4):212-20. doi: 10.1097/00005792-199507000-00005. Medicine (Baltimore). 1995. PMID: 7623656 Review.
Cited by
-
Cocaine self-administration produces pharmacodynamic tolerance: differential effects on the potency of dopamine transporter blockers, releasers, and methylphenidate.Neuropsychopharmacology. 2012 Jun;37(7):1708-16. doi: 10.1038/npp.2012.17. Epub 2012 Mar 7. Neuropsychopharmacology. 2012. PMID: 22395730 Free PMC article.
-
Typology of alcohol users based on longitudinal patterns of drinking.Addict Behav. 2014 Mar;39(3):607-21. doi: 10.1016/j.addbeh.2013.11.013. Epub 2013 Nov 27. Addict Behav. 2014. PMID: 24333036 Free PMC article.
-
Outlier populations: individual and social network correlates of solvent-using injection drug users.PLoS One. 2014 Feb 11;9(2):e88623. doi: 10.1371/journal.pone.0088623. eCollection 2014. PLoS One. 2014. PMID: 24523923 Free PMC article.
-
First-time admissions for opioid treatment: cross-sectional and descriptive study of new opioid users seeking treatment.Neuropsychiatr Dis Treat. 2015 Sep 24;11:2431-40. doi: 10.2147/NDT.S84431. eCollection 2015. Neuropsychiatr Dis Treat. 2015. PMID: 26445539 Free PMC article.
-
Sensitized nucleus accumbens dopamine terminal responses to methylphenidate and dopamine transporter releasers after intermittent-access self-administration.Neuropharmacology. 2014 Jul;82:1-10. doi: 10.1016/j.neuropharm.2014.02.021. Epub 2014 Mar 13. Neuropharmacology. 2014. PMID: 24632529 Free PMC article.
References
-
- HIV/AIDS Epi Update, August 2006. Ottawa, ON: Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada; 2006.
-
- Miller CL, Wood E, Spittal P, et al. The future face of coinfection: prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug users. J Acquir Immune Defic Syndr. 2004;36: 743–749. - PubMed
-
- Bourliere M, Barberin JM, Rotily M, et al. Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users. J Viral Hepat. 2002;9:62–70. - PubMed
-
- Ouellet L, Huo D, Bailey SL. HIV risk practices among needle exchange users and nonusers in Chicago. J Acquir Immune Defic Syndr. 2004;37:1187–1196. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources